Ayr Wellness: Fourth Quarter Consensus Estimates

Ayr Wellness (CSE: AYR.a) is set to report their fourth quarter and year end financials before market open on March 11th. Analysts have a consensus C$54.60 12-month price target on the company, via a total of four analysts, with one analyst having a strong buy rating and the other three have buy ratings. The street high comes from Beacon Securities with a C$76 price target, and the lowest target comes from PI Financial with a C$60 price target.

Three analysts have revenue estimates for the fourth quarter. The mean between all three is U$48.57 million; this number has been revised upwards from U$47.13 million at the start of the year.

For the full year, the average estimate between three analysts is currently U$155.77 million. This number has stayed flat since the start of the year.

Onto EBITDA estimates, there are currently three analysts who have fourth-quarter EBITDA estimates. The mean is currently U$20.45 million, with this number being revised upwards from U$19.63 million at the start of the year.

For the full-year the current EBITDA means across three analysts is U$57.2 million, with that number basically staying flat year-to-date.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The Goal is Gold Production as Soon as Possible! | Gordon Robb – ESGOLD Corp.

Snowline Gold: The Multi Billion Dollar Valley PEA

Euro Sun: Rovina Copper-Gold Project Secures Some Major Funding

Recommended

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Related News

Equinox Gold: Mercedes Mine Sale Was “A Favourable Sale Price For A Non-Core Asset”

On December 17th, Equinox Gold (TSX: EQX) announced that they reached an agreement to sell...

Sunday, December 26, 2021, 02:14:00 PM

Organigram: Analysts Upgrade Targets Following BAT Investment

On March 9th, Organigram Holdings (TSX: OGI) (NASDAQ: OGI) announced that they received a C$221...

Sunday, March 14, 2021, 06:32:00 PM

Cineplex: Canaccord Lowers Target To $17 From $19

On February 11th, Cineplex Inc (TSX: CGX) reported its fourth quarter financial results. The company...

Tuesday, February 15, 2022, 05:17:00 PM

Ayr Wellness: Canaccord Reiterates $70 Price Target Following Earnings

Earlier this week, Ayr Wellness (CSE: AYR.a) reported their first-quarter earnings. The company reported revenues...

Friday, May 28, 2021, 04:02:00 PM

Raymond James: Village Farms Selloff Is Overdone

Village Farms International, Inc. (TSX: VFF) investors are having a rough start to the month,...

Wednesday, May 12, 2021, 02:36:00 PM